The GeneXpert diagnostic testing technology from the US corporation Cepheid, and its parent company Danaher, has revolutionised rapid, accurate diagnosis of tuberculosis (TB) and other diseases, since entering the market in 2010. Yet, due to the high cost of the GeneXpert test cartridges, many countries are not able to scale up testing for all people who need lifesaving diagnosis and subsequent treatment.
In light of the shockingly low vaccination rates in South Africa and other African countries, seven organizations from South Africa have sent a letter appealing for the German government to support the immediate suspension of patents ...
As the omicron variant spreads, MSF calls on Moderna and Pfizer-BioNTech to immediately share their lifesaving mRNA vaccine technology with manufacturers that stand ready to boost the global supply
Recently the World Health Organization (WHO) approved several biological drugs to treat COVID-19 disease. This is the first time that the organisation has moved so quickly to list monoclonal antibodies, popularly called mAbs, for the treatment of a disease. But will they reach the patients who need them?
MSF and supporters urge high-income countries blocking the landmark TRIPS Waiver to put proclaimed global solidarity into practice and support the Waiver now
MSF welcomes the announcement by the World Health Organization (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) of the first global, non-exclusive and transparent voluntary license for a COVID-19 ...
Pfizer recently shared positive interim results for its COVID-19 oral antiviral investigational candidate PF-07321332 in combination with ritonavir (Paxlovid), which is considered a promising treatment, pending regulatory review, WHO ...
In this video, MSF staff working in places where people have been severely affected by COVID-19 speak out about their experiences, and how the lack of access to COVID-19 vaccines has impacted the communities where they work.
Response to Moderna putting profit before global public health, MSF tells the corporation to share mRNA vaccine technology and know-how through the World Health Organization's COVID-19 mRNA vaccine technology transfer hub in South ...
Today the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced the approval of molnupiravir for the early treatment of people with mild to moderate COVID-19 who are at increased risk of developing severe disease.
If so, you have a moment right now to stand by the millions of unvaccinated people across the world by demanding that US pharmaceutical corporation, Moderna, urgently shares its COVID-19 vaccine recipe – which was predominantly funded by the public.
Following another misleading attempt by the EU to undermine the TRIPS Waiver, MSF calls on the EU stop derailing and support the original Waiver proposal being led by India and South Africa.